via The Scientist RSS https://ift.tt/V5A2oxQkt Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today introduced four inhibitory antibodies that are highly specific to pertuzumab (Perjeta). https://ift.tt/HIjAfVXiW February 03, 2022 at 04:00AM